Karyopharm initiated at B. Riley FBR

Karyopharm initiated with a Buy at B. Riley FBR. B. Riley FBR analyst Harshita Polishetty started Karyopharm Therapeutics with a Buy rating and $23 price target.
https://thefly.com/landingPageNews.php?id=2830607